Another study showed GLP-1 agonist use to be associated with lower risks for several substance use disorders." To view or add a comment, sign in A team of researchers from The National Institutes of Health (NIH), Copenhagen University Hospital, and international collaborators has reported the first evidence from a randomised controlled clinical trial showing that a GLP-1 receptor agonist may help reduce heavy drinking in people living with both #obesity and #alcohol use disorder
If you find yourself constantly battling fatigue or low energy despite a balanced diet and adequate sleep, a glutathione IV drip can help recharge your system
indicate that approximately 20% of patients reported vomiting as a side effect, highlighting that this is a notable complication that sometimes requires prompt attention and management
SeekPeptides members frequently discuss optimal syringe selection for high-concentration vials in the community forums, and the consensus is clear: smaller syringes produce more accurate doses at this concentration
Its exciting that these diabetes medications may offer additional benefits, such as protecting brain health, said Serena Jingchuan Guo, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy at the University of Florida, in a news release